Ondexxya approved in Japan for reversal of acute major bleeds in patients on Factor Xa inhibitors
Ondexxya is the first approved reversal agent specifically for Factor Xa inhibitors, providing a major advance in the treatment of patients hospitalised with life-threatening bleeding